MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting Results Show Durable...
Development of novel therapeutic antibody approach being evaluated in clinical trials for patients with multiple myeloma MorphoSys will...
MorphoSys and Xencor Report Clinical Data for MOR208/XmAb5574 /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; co...
MorphoSys AG (FSE: MOR; Prime Standard Segment; TecDAX) and US-based biopharmaceutical company Xencor, Inc., announced today the...
RNS Number:4093U Morse PLC 20 January 2004 20 January 2004: Embargoed for 7.00am Morse plc Sales performance update for Q2 Interim...
RNS Number:5391T Morse PLC 22 December 2003 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) NAME OF...
RNS Number:7228S Morse PLC 02 December 2003 Embargoed for 07.00hrs, Tuesday 2 December 2003 Morse plc Morse completes acquisition of...
RNS Number:0406S Morse PLC 13 November 2003 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) NAME OF...
RNS Number:9598R Morse PLC 12 November 2003 Morse plc Morse announces the acquisition of Systematics Technology Solutions GmbH, a...
RNS Number:6253R Morse PLC 04 November 2003 Embargoed for 7.00am, Tuesday 4 November 2003 Morse plc AGM statement and Q1 sales...
RNS Number:2913R Morse PLC 24 October 2003 SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN To: Listing Applications UK Listing Authority...
RNS Number:8384Q Morse PLC 13 October 2003 Morse PLC ('the Company') Additional Listing Application has been made to the UK Listing...
RNS Number:1974Q Morse PLC 25 September 2003 Morse plc Section 198 Companies Act 1985 (as amended) Disclosure of Interests...
RNS Number:1842P Morse PLC 29 August 2003 Morse PLC Morse PLC announces the following forthcoming dates in its financial calendar for...
RNS Number:1574P Morse PLC 29 August 2003 Embargoed for 07.01hrs, Friday 29 August 2003 29 August 2003 Morse plc Preliminary...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads